Lin, Chia-Chi
Arkenau, Hendrik-Tobias
Lu, Sharon
Sachdev, Jasgit
de Castro Carpeño, Javier
Mita, Monica
Dziadziuszko, Rafal
Su, Wu-Chou
Bobilev, Dmitri
Hughes, Lorraine
Chan, Jian
Zhang, Zhi-Yi
Weiss, Glen J.
Funding for this research was provided by:
This clinical trial was funded by TESARO, Inc.
Article History
Received: 20 December 2018
Revised: 14 May 2019
Accepted: 21 May 2019
First Online: 20 June 2019
Competing interests
: C.-C.L., H.-T.A., M.M. and W.-C.S. declare no conflict of interest. J.S. reports advisory board, consulting, travel support and grant funding for investigator-initiated trials from Celgene, drug support for investigator-initiated trials from Genentech, funding for investigator-initiated trials from Pfizer and advisory board and consulting fees from TapImmune. J.d.C.C. reports advisory fees from AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Pfizer, Roche and Takeda. R.D. reports personal fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Pfizer and Roche. G.J.W. reports ownership interest from Circulogene, personal fees from Circulogene, GLG Council, Guidepoint Global, IDEA Pharma, Ignyta, Paradigm, Pfizer, Angiex, Imaging Endpoints, Spring Bank Pharmaceuticals, and IBEX Medical Analytics, travel and lodging fees from Cambridge Healthtech Institute, GlaxoSmithKline, and TESARO, and holds a patent (PCT/US2014/8911940) outside the submitted work. S.L., D.B., L.H., J.C. and Z.-Y.Z. are employees and stockholders of TESARO: A GSK Company.
: This clinical investigation was conducted in compliance with Good Clinical Practice, the Declaration of Helsinki (version 2008) and other applicable regulatory requirements. The protocol was approved by the Institutional Review Board at each participating site (for a list of institutions see Table InternalRef removed of Supplemental Information, available at <i>British Journal of Cancer</i> website), and all patients provided written informed consent before study participation.
: This clinical trial was funded by TESARO: A GSK Company Writing and editorial support were funded by TESARO and coordinated by Hemant Vyas, PhD, of TESARO.
: Not applicable.
: The data on internal records will be provided upon request.